Futura Medical plc (FAMDF)

Market Cap	8.50M
Revenue (ttm)	10.86M
Net Income (ttm)	-8.62M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	41,157
Open	0.0200
Previous Close	0.0110
Day's Range	0.0200 - 0.0300
52-Week Range	0.0013 - 0.4500
Beta	0.48
RSI	50.88
Earnings Date	Dec 12, 2025

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: OTCMKTS
• Ticker Symbol: FAMDF

Financial Performance

Financial numbers in GBP